NL-OMON55181
Withdrawn
Not Applicable
Glycemic control in the intensive care unit assisted by Glycostat, a continuos central venous blood glucose measurement system with an algorithm giving advice on insulin infusion rate - Glycemic control in the ICU assisted by Glycostat
Medische Hulpmiddelen Industrie0 sites20 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Medische Hulpmiddelen Industrie
- Enrollment
- 20
- Status
- Withdrawn
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •Male and Female subjects, age \>\= 18 years, \<\= 85 years
- •ICU patients (any type) with an Arrow 3, 4 or 5 lumen central venous catheter
- •in place (CVC in situ not for study,
- •but part of standard practice)
- •Clinical parameters (vital signs, medical history, and physical examination)
- •not clinically significant or unstable as
- •determined by the principal investigator.
- •Informed consent obtained before any activities related to the investigation
Exclusion Criteria
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •Known or suspected allergy to device material
- •Not eligible to receive IV insulin
- •ICU patients without Arrow 3 lumen or 4 or 5 lumen central venous catheter in
- •Previous participation (defined as participation on Day 1\) in this trial.
- •Acute and/or severe chronic illness or history of any illness that, in the
- •opinion of the Investigator, might pose additional risk in applying the
- •Glycostat probe to the subject
- •Participation in another investigational study within 30 days prior to
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
Not Applicable
Glycemic control in the intensive care unit assisted by Glycostat, a continuos central venous blood glucose measurement system with an algorithm giving advice on insulin infusion rateNL-OMON49462Medische Hulpmiddelen Industrie20
Terminated
Phase 2
iberal blood glucose control in critically ill patients with pre-existing type 2 diabetes.Type 2 DiabetesCritical illnessMetabolic and Endocrine - DiabetesACTRN12616001135404Royal Adelaide Hospital436
Completed
Phase 4
Strict Glycemic Control by Insulin Infusion:Observations on Emergency Department InitiationHyperglycemiaNCT00779701Temple University27
Active, not recruiting
Not Applicable
Optimizing of blood sugar control for surgical patients with diabetes type 2.Diabetes type 2.MedDRA version: 16.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Hormonal diseases [C19]EUCTR2013-002936-26-DKChristoffer Hedetoft
Completed
Not Applicable
Automatic insulin therapy in critically ill patients; Randmized cross-over controlled studyAdult ICU patients expected to stay for more than 3 days and had acute hyperglycemia defined as >150 mg/dJPRN-UMIN000003733Department of Anesthesiology and Resuscitology, Okayama University Hospital24